» Articles » PMID: 33708587

Efficacy of Platelet-Rich Plasma and Concentrated Growth Factor in Treating Androgenetic Alopecia - A Retrospective Study

Overview
Date 2021 Mar 12
PMID 33708587
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Plasma derivatives have been practiced a lot in orthopedics, burns, and sport medicine. Microneedling (MN) with platelet-rich plasma (PRP) therapy has been proven to improve the micro-circulation and thus improve hair growth. The role of concentrated growth factor (CGF) for hair growth has not been mentioned anywhere in the literature for hair growth which we tried to prove in our article by comparing it with various other studies.

Materials And Methods: This is a retrospective randomized study involving 20 male patients whose ages ranged from 21 years to 56 years. PRP was prepared using the dual-spin method and injected after activation; post-MN, CGF gel was applied topically. Four sessions were performed, and a follow-up was done after 6 months. Statistical analysis was done using the Statistical Package for the Social Sciences software version 21 for Windows (SPSS, IBM Corp, Armonk, NY, USA). Paired -test was used for the various comparisons.

Results: Hair loss reduced by the end of the first month. At the end of 6 months, postfirst session, microscopic examination showed statistically significant difference in the hair count compared to those during the baseline.

Discussion: PRP having platelet-derived growth factor and vascular endothelial growth factor acts on stem cells in the follicles, stimulating the development of new follicles and promoting neovascularization. CGF helps stimulating cell proliferation and matrix remodeling due to numerous growth factors in a concentrated form. Thus, this therapy combined helps to boost the hair growth in a very significant way.

Summary: This study provides the preliminary evidence of efficacy of PRP along with MN and CGF in treating androgenetic alopecia by promoting angiogenesis along with vascularization and promotes hair follicles to enter and extend the anagen phase. Most of the results obtained show improved results with this therapy. A larger case study for the same can further be done for a stronger recommendation of the use of CGF for hair growth therapy further.

Citing Articles

Progress on mitochondria and hair follicle development in androgenetic alopecia: relationships and therapeutic perspectives.

Dong T, Li Y, Jin S, Yang F, Xiong R, Dai Y Stem Cell Res Ther. 2025; 16(1):44.

PMID: 39901201 PMC: 11792644. DOI: 10.1186/s13287-025-04182-z.


Autologous Growth Factor-Rich Concentrate (GFC) Injection in Non-union of Fractures: A Quasi-experimental Study.

Jain K, Jeyaraman M, Jeyaraman N, Gupta A Indian J Orthop. 2024; 58(12):1833-1843.

PMID: 39664350 PMC: 11628475. DOI: 10.1007/s43465-024-01278-1.


Combination Therapy With CGF and Microneedling-Assisted Compound Betamethasone for Resistant Alopecia Areata: A Pilot Study.

Jia L, Zhao C, Zhang H, Jiang H, Xiong J, Li Y J Cosmet Dermatol. 2024; 24(1):e16591.

PMID: 39305097 PMC: 11742920. DOI: 10.1111/jocd.16591.


Evaluation of the safety and efficacy of concentrated growth factors for hair growth promotion in androgenetic alopecia patients: A retrospective single-centre, single-arm study.

Cao S, Zhu M, Bi Y J Cosmet Dermatol. 2024; 23(12):4051-4056.

PMID: 39169643 PMC: 11626311. DOI: 10.1111/jocd.16519.


Application of Non-Pharmacologic Therapy in Hair Loss Treatment and Hair Regrowth.

Huang X, Zhao P, Zhang G, Su X, Li H, Gong H Clin Cosmet Investig Dermatol. 2024; 17:1701-1710.

PMID: 39071847 PMC: 11283242. DOI: 10.2147/CCID.S471754.


References
1.
Schmitt L, Marquardt Y, Amann P, Heise R, Huth L, Wagner-Schiffler S . Comprehensive molecular characterization of microneedling therapy in a human three-dimensional skin model. PLoS One. 2018; 13(9):e0204318. PMC: 6147558. DOI: 10.1371/journal.pone.0204318. View

2.
Alves R, Grimalt R . Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia. Dermatol Surg. 2016; 42(4):491-7. DOI: 10.1097/DSS.0000000000000665. View

3.
Fertig R, Gamret A, Darwin E, Gaudi S . Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review. Dermatol Online J. 2018; 23(11). View

4.
Han J, Kwon O, Chung J, Cho K, Eun H, Kim K . Effect of minoxidil on proliferation and apoptosis in dermal papilla cells of human hair follicle. J Dermatol Sci. 2004; 34(2):91-8. DOI: 10.1016/j.jdermsci.2004.01.002. View

5.
Blumeyer A, Tosti A, Messenger A, Reygagne P, Del Marmol V, Spuls P . Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Dtsch Dermatol Ges. 2011; 9 Suppl 6:S1-57. DOI: 10.1111/j.1610-0379.2011.07802.x. View